Table 2.
Mortality Outcome and Decile of ALT Levela | No. of Deaths | Unadjusted Cumulative Mortalityb | Age-adjusted Hazard Ratioc | 95% Confidence Interval | P Value |
---|---|---|---|---|---|
All causes | |||||
1 | 816 | 34.6 | 1.61 | 1.41, 1.83 | <0.001 |
2 | 393 | 29.4 | 1.42 | 1.20, 1.68 | <0.001 |
3 | 494 | 26.6 | 1.28 | 1.08, 1.53 | 0.006 |
4–9 | 1,760 | 17.5 | 1.00 | ||
10 | 211 | 17.4 | 1.33 | 1.06, 1.66 | 0.014 |
Cardiovascular disease | |||||
1 | 329 | 16.2 | 1.64 | 1.35, 1.98 | <0.001 |
2 | 159 | 9.3 | 1.32 | 1.00, 1.75 | 0.047 |
3 | 187 | 11.6 | 1.26 | 0.90, 1.75 | 0.17 |
4–9 | 626 | 6.6 | 1.00 | ||
10 | 63 | 4.2 | 1.23 | 0.83, 1.81 | 0.30 |
Cancer | |||||
1 | 173 | 8.6 | 1.73 | 1.35, 2.21 | <0.001 |
2 | 89 | 11.0 | 1.64 | 1.21, 2.22 | 0.002 |
3 | 114 | 7.1 | 1.46 | 1.02, 2.08 | 0.038 |
4–9 | 398 | 4.4 | 1.00 | ||
10 | 44 | 5.2 | 0.95 | 0.61, 1.48 | 0.82 |
Diabetes mellitus | |||||
1 | 19 | 0.63 | 1.06 | 0.44, 2.55 | 0.89 |
2 | 11 | 0.76 | 1.86 | 0.77, 4.52 | 0.16 |
3 | 12 | 0.18 | 0.41 | 0.20, 0.85 | 0.017 |
4–9 | 63 | 0.54 | 1.00 | ||
10 | 11 | 1.7 | 2.74 | 0.97, 7.73 | 0.056 |
Liver diseased | |||||
1 | 2 | 0.004 | 0.02 | 0.003, 0.12 | <0.001 |
2 | 1 | 0.046 | 0.25 | 0.036, 1.71 | 0.15 |
3 | 3 | 0.028 | 0.15 | 0.031, 0.73 | 0.020 |
4–9 | 15 | 0.20 | 1.00 | ||
10 | 16 | 0.70 | 5.27 | 1.59, 17.46 | 0.008 |
Other | |||||
1 | 293 | 14.1 | 1.54 | 1.28, 1.85 | <0.001 |
2 | 133 | 11.8 | 1.35 | 1.07, 1.69 | 0.011 |
3 | 178 | 10.4 | 1.27 | 1.00, 1.62 | 0.049 |
4–9 | 658 | 6.9 | 1.00 | ||
10 | 77 | 6.8 | 1.47 | 1.07, 2.02 | 0.017 |
Abbreviation: ALT, alanine aminotransferase.
a ALT cutpoints were 9, 11, 13, and 33 IU/L for men and 7, 8, 9, and 22 IU/L for women.
b Estimated using Kaplan-Meier analysis.
c Estimated using Cox proportional hazards regression analysis with age as a continuous variable.
d Nonmalignant liver disease.